These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32087088)

  • 41. Generation of CD4CreER(T²) transgenic mice to study development of peripheral CD4-T-cells.
    Aghajani K; Keerthivasan S; Yu Y; Gounari F
    Genesis; 2012 Dec; 50(12):908-13. PubMed ID: 22887772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice.
    Rossi M; Salomon A; Chaumontel N; Molet J; Bailly S; Tillet E; Bouvard C
    Sci Rep; 2023 Apr; 13(1):5976. PubMed ID: 37045870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
    Zhang H; Fujitani Y; Wright CV; Gannon M
    Genesis; 2005 Jul; 42(3):210-7. PubMed ID: 15986486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of knock-in mice that express nuclear enhanced green fluorescent protein and tamoxifen-inducible Cre recombinase in the notochord from Foxa2 and T loci.
    Imuta Y; Kiyonari H; Jang CW; Behringer RR; Sasaki H
    Genesis; 2013 Mar; 51(3):210-8. PubMed ID: 23359409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.
    Bosenberg M; Muthusamy V; Curley DP; Wang Z; Hobbs C; Nelson B; Nogueira C; Horner JW; Depinho R; Chin L
    Genesis; 2006 May; 44(5):262-7. PubMed ID: 16676322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo imaging and noninvasive ablation of pyramidal neurons in adult NEX-CreERT2 mice.
    Agarwal A; Dibaj P; Kassmann CM; Goebbels S; Nave KA; Schwab MH
    Cereb Cortex; 2012 Jul; 22(7):1473-86. PubMed ID: 21880656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line.
    Pimeisl IM; Tanriver Y; Daza RA; Vauti F; Hevner RF; Arnold HH; Arnold SJ
    Genesis; 2013 Oct; 51(10):725-33. PubMed ID: 23897762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme.
    Inoue S; Inoue M; Fujimura S; Nishinakamura R
    Genesis; 2010 Mar; 48(3):207-12. PubMed ID: 20127799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity.
    Kemp R; Ireland H; Clayton E; Houghton C; Howard L; Winton DJ
    Nucleic Acids Res; 2004; 32(11):e92. PubMed ID: 15247325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase.
    Danielian PS; Muccino D; Rowitch DH; Michael SK; McMahon AP
    Curr Biol; 1998 Dec; 8(24):1323-6. PubMed ID: 9843687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.
    Qiu HY; Guo C; Cheng XW; Huang Y; Xiong ZQ; Ding YQ
    Genesis; 2008 Jun; 46(6):324-8. PubMed ID: 18543300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control.
    Felker A; Nieuwenhuize S; Dolbois A; Blazkova K; Hess C; Low LW; Burger S; Samson N; Carney TJ; Bartunek P; Nevado C; Mosimann C
    PLoS One; 2016; 11(4):e0152989. PubMed ID: 27077909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
    Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
    Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases.
    Feil S; Krauss J; Thunemann M; Feil R
    Methods Mol Biol; 2014; 1194():113-39. PubMed ID: 25064100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A New Autosomal
    Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporally controlled somatic mutagenesis in smooth muscle.
    Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
    Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
    Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.